Aurinia Pharmaceuticals (AUPH) PT Raised to $18 at TD Cowen
TD Cowen analyst Stacy Ku raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $18.00 (from $17.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

